Abstract
E-cigarette, or vaping, product use-associated lung injury (EVALI) has become an epidemic that is increasingly affecting patients across USA. Recently, over 2100 cases have been reported in 49 states, resulting in at least 42 deaths. We present a case of rapid respiratory failure in an otherwise healthy and young patient who used a vaporiser containing tetrahydrocannabinol (THC) during the month prior to admission. The patient eventually required mechanical ventilation. There were significant challenges in achieving the appropriate level of sedation during intubation and mechanical ventilation. As more EVALI cases are being diagnosed in recent months, we highlight an aspect that may be unique to the population of patients who vaporise THC—high sedative and analgesic requirements during intubation and mechanical ventilation.
Reference20 articles.
1. Update: interim guidance for health care providers for managing patients with suspected E-cigarette, or vaping, product Use-associated lung injury - United States, November 2019;Jatlaoui;MMWR Morb Mortal Wkly Rep,2019
2. Severe Pulmonary Disease Associated with Electronic-Cigarette-Product Use - Interim Guidance;Schier;MMWR Morb Mortal Wkly Rep,2019
3. Pulmonary illness related to E-Cigarette use in Illinois and Wisconsin - final report;Layden;N Engl J Med,2020
4. Federal Drug Agency . E-Cigarette products: safety communication – due to the incidents of severe respiratory disease associated with use of an e-cigarette product, 2019. Available: https://www.fda.gov/safety/medwatch-safety-alerts-human-medical-products/e-cigarette-products-safety-communication-due-incidents-severe-respiratory-disease-associated-use-e [Accessed 3 Dec 2019].
5. Outbreak of electronic-cigarette-associated acute lipoid pneumonia - North Carolina, july-august 2019;Davidson;MMWR Morb Mortal Wkly Rep,2019